"Because of Bupa, I am able to have it, but that runs out at the end of January. The medical insurance only lasts a year. I would hope to have destroyed the tumour by then.
"[But] If I hadn't have had the drug, I would still have fought it and I still would have won.
"There's lots of people with different situations, if the tumour is small, they won't put you on to a drug, because they'll look at a transplant.
They've got a pretty hard job to do. I've got a lot of sympathy for them, we've all got to make budgeting decisions
"Once a transplant can't happen, that's when they consider the drug - you're talking about people in a very serious condition. That's why they're talking about only extending the life for six months.
"I just think it's a case of really, we as human beings in a society, should re-evaluate our priorities.
"Other countries have access to drugs that could make a difference because they have a different set of priorities.
"They've [NICE] got a pretty hard job to do. I've got a lot of sympathy for them - we've all got to make budgeting decisions.
"The chemical companies themselves have just as much responsibility as NICE, if they want to sell their product at a price we can't afford. Why are they putting it out at that price? I'm pretty sure it's because they want to make profit for their shareholders."